Suzhou Pharma Services Announces New US Corporate Offices In Lyndhurst, NJ And Our FDA Approved And Chinese SFDA Licensed Manufacturing Facility In Suzhou, China

Suzhou Pharma Services, an affiliate of Amerigen Pharmaceuticals, a new contract development and manufacturing organization specializing in solid oral dosage forms, is proud to announce the location of our new corporate headquarters in Lyndhurst, New Jersey and the company’s primary manufacturing facility located in Suzhou, China. Suzhou Pharma Services is one of China’s first US FDA approved and Chinese SFDA licensed finished product cGMP manufacturing sites. Our corporate US office includes the Senior Management Team, R&D, Regulatory Affairs and Quality Heads, a US based Product Development and Project Management Team, and Business Development.

The management team in China is comprised of highly experienced, Western trained leaders, averaging 20+ years of experience with multi-national branded and generic pharmaceutical companies. Our mission at Suzhou Pharma Services is to provide our customers innovative and reliable solutions to their solid oral dose development and manufacturing needs, under the highest levels of quality and customer service standards available in the industry. We combine Western pharmaceutical experience, expertise and cGMP quality standards with Chinese production at a very attractive value proposition. We are solely focused on solid oral dosages with a highly skilled and trained workforce. Our customer service and project teams are local and US based, facilitating all interactions and acting as a conduit for all communications. We can offer lower cost advantages through reduced labor costs, higher productivity and lower cost raw materials.

Suzhou Pharma Services can deliver to pharmaceutical manufactures’ not only cost savings and high quality products for Western and Global Markets, but also a local manufacturing solution for access to the growing Chinese pharmaceutical marketplace.

Where Western Pharmaceutical Experience meets Eastern Manufacturing Potential. For more information, visit  www.suzhoupharma.com